Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis

Multiple Sclerosis

Volumn 21, Issue 6, 2015, Pages 710-717

  Hyun, Jae Won ^a   Kim, Su Hyun ^a   Huh, So Young ^b   Kim, Woojun ^c   Yun, Junglim ^a   Joung, Aeran ^a   Sato, Douglas Kazutoshi ^d   Fujihara, Kazuo ^d   Kim, Ho Jin ^a  

^a National Cancer Center   (South Korea)

^b Kosin University   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

aquaporin 4 antibody; idiopathic; Longitudinally extensive transverse myelitis; neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADOLESCENT; ADULT; AGE; ANTIBODY DETECTION; ARTICLE; ASTROCYTE; CELL DAMAGE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS; MAJOR CLINICAL STUDY; MALE; MYELITIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN CEREBROSPINAL FLUID LEVEL; SERODIAGNOSIS; SEX DIFFERENCE; BLOOD; CEREBROSPINAL FLUID; CLASSIFICATION; IMMUNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AQUAPORIN 4; AUTOANTIBODIES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MYELITIS, TRANSVERSE; REGISTRIES; SEX FACTORS; YOUNG ADULT;

EID: 84930518044     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514551454     Document Type: Article

References (34)

1. Kitley JL, Leite MI, George JS, et al. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler. 2012 ; 18: 271-285
2. Trebst C, Raab P, Voss EV, et al. Longitudinal extensive transverse myelitis - it's not all neuromyelitis optica. Nat Rev Neurol. 2011 ; 7: 688-698
3. Scott TF, Bhagavatula K, Snyder PJ, et al. Transverse myelitis. Comparison with spinal cord presentations of multiple sclerosis. Neurology. 1998 ; 50: 429-433
4. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489
5. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112
6. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 ; 59: 566-569
7. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol. 2008 ; 65: 913-919
8. Iorio R, Damato V, Mirabella M, et al. Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies. J Neurol. 2013 ; 260: 2396-2402
9. Kitley J, Leite MI, Kuker W, et al. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol. 2013 ; 70: 1375-1381
10. Marignier R, Bernard-Valnet R, Giraudon P, et al. Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology. 2013 ; 80: 2194-2200
11. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicenter study of 175 patients. J Neuroinflammation. 2012 ; 9: 14
12. Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation. 2011 ; 8: 184
13. Kitley J, Woodhall M, Waters P, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology. 2012 ; 79: 1273-1277
14. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014 ; 82: 474-481
15. Chan KH, Ramsden DB, Yu YL, et al. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Eur J Neurol. 2009 ; 16: 310-316
16. Kim SH, Kim SM, Vincent A, et al. Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis. J Neurol. 2010 ; 257: 920-925
17. Qiu W, Wu JS, Zhang MN, et al. Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database. J Neurol Neurosurg Psychiatry. 2010 ; 81: 209-212
18. Chang KH, Lyu RK, Chen CM, et al. Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies. Mult Scler. 2013 ; 19: 299-307
19. Kim SM, Waters P, Woodhall M, et al. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders. Mult scler. 2013 ; 19: 1060-1067
20. Kim KK. Idiopathic recurrent transverse myelitis. Arch Neurol. 2003 ; 60: 1290-1294
21. Pawate S, Sriram S. Isolated longitudinal myelitis: a report of six cases. Spinal cord. 2009 ; 47: 257-261
22. Ravaglia S, Bastianello S, Franciotta D, et al. NMO-IgG-negative relapsing myelitis. Spinal cord. 2009 ; 47: 531-537
23. Alvarenga MP, Alvarenga RM, Alvarenga MP, et al. Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis. J Spinal Cord Med. 2012 ; 35: 251-255
24. Jiao Y, Fryer JP, Lennon VA, et al. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2013 ; 71: 48-54
25. Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology. 2010 ; 75: 208-216
26. Jarius S, Probst C, Borowski K, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci. 2010 ; 291: 52-56
27. Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology. 2013 ; 80: 2210-2216
28. Kim W, Lee JE, Li XF, et al. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4. Mult Scler. 2012 ; 18: 578-586
29. McKeon A, Pittock SJ, Lennon VA. CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology. 2011 ; 76: 1108-1110
30. Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol. 2010 ; 6: 383-392
31. Jiao Y, Fryer JP, Lennon VA, et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013 ; 81: 1197-1204
32. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012 ; 78: 665-671
33. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008 ; 131: 3072-3080
34. Li R, Qiu W, Lu Z, et al. Acute transverse myelitis in demyelinating diseases among the Chinese. J Neurol. 2011 ; 258: 2206-2213